TL;DR
A 12-week study in people with coronary artery disease found that CoQ10 supplementation lowered inflammatory markers (IL-6 and malondialdehyde). Higher doses produced greater reductions. Educational only; work with doctors trained in natural healthcare.
Educational purposes only
A randomized, placebo-controlled study published in Nutrition (March 2012; 28(3):250–255) looked at whether CoQ10 supplementation could reduce inflammation in people with coronary artery disease. Forty subjects were divided into three groups and received either 150 mg of CoQ10, 60 mg of CoQ10, or a placebo daily for 12 weeks.
At the end of the study, both CoQ10 groups showed higher plasma levels of CoQ10. More importantly, markers of inflammation — including interleukin-6 (IL-6) and malondialdehyde — were significantly lower in those receiving CoQ10. The higher the CoQ10 dose, the greater the reduction in inflammatory markers.
These findings suggest that CoQ10 may help support a healthier inflammatory response, particularly in individuals with cardiovascular concerns. This information is educational only and not intended as medical advice.
FAQ
Does CoQ10 help reduce inflammation?
Research shows CoQ10 can lower markers like IL-6 and malondialdehyde, particularly in cardiovascular patients.
Is a higher dose more effective?
In this study, inflammation decreased more with the 150 mg dose than with 60 mg.
Is CoQ10 safe to take long-term?
CoQ10 is generally well-tolerated, but supplementation should be discussed with doctors trained in natural healthcare.
